Showing 18,061 - 18,080 results of 107,763 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.99s Refine Results
  1. 18061
  2. 18062
  3. 18063

    <i>Bbs1</i><sup><i>M390R/M390R</i></sup> mice have decreased hippocampal proliferation. by Thomas K. Pak (10686881)

    Published 2021
    “…<p>A.) Normalized initial slope (%) recordings of field excitatory post synaptic potentials (fEPSP) in the hippocampal CA1 Schaffer-collateral pathway between 2 month male control mice (n = 17, 4 mice) and <i>Bbs1</i><sup><i>M390R/M390R</i></sup> mice (n = 16, 4 mice). …”
  4. 18064
  5. 18065
  6. 18066
  7. 18067
  8. 18068
  9. 18069
  10. 18070
  11. 18071
  12. 18072

    Inhibition of the interactions of syndecan-1 with integrins αvβ3 and αvβ5 was inhibited with the synstatin and gene or protein expression was measured after 48 hours. by Somali Chaterji (527203)

    Published 2014
    “…<p>(A–C) Decreased expression of vSMC-specific differentiation markers; (D–F) Increased expression of inflammatory cytokine, MCP-1, and, adhesion receptors, ICAM-1 and VCAM-1.…”
  13. 18073

    Mutagenesis of the CXCL10 binding site on <i>L</i>. <i>(L</i>.<i>) major</i> GP63 to <i>L</i>. <i>(V</i>.<i>) panamensis</i> residues reduces CXCL10 cleavage and T cell chemotaxis. by Alejandro L. Antonia (7147739)

    Published 2021
    “…(L.) major gp63 <i>allele (D463) to the</i> L. (V.) panamensis <i>allele (N463) at the CXCL10 binding site decreases CXCR3</i><sup><i>+</i></sup> <i>T cell chemotaxis</i>. …”
  14. 18074

    A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model by Paul Walsh (662015)

    Published 2016
    “…Ibuprofen is a prototypical non-steroidal anti-inflammatory drug that decreases PGE<sub>2</sub> levels by inhibiting cyclooxygenase.…”
  15. 18075
  16. 18076
  17. 18077

    M2b group mean (and standard error) lines of best fit for the normalized integrated wrist flexor EMG values as a function of trial-by-trial foreperiod length. by Christopher J. Forgaard (3210876)

    Published 2016
    “…ACT conditions: dashed lines. A. Short foreperiod (2.5–3.5s) conditions. B. Long foreperiod (2.5–10.5s) conditions. …”
  18. 18078

    Impaired expression of <i>bmp4</i>, <i>fgf8a, and1</i> and <i>msx</i> genes in the pectoral fin region of <i>dlx5a/6a</i> morphants. by Églantine Heude (568153)

    Published 2014
    “…In contrast to what is observed in controls at 48 hpf, <i>dlx5a/6a</i> morphants show a marked decrease or loss of expression of the PFB markers associated with pectoral fin agenesis (B′–D′, F′, H′). …”
  19. 18079
  20. 18080